Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INvestigating Sex and Gender-Related Differences in Immunotherapy Treatment Effects (INSITE)

NCT06562777 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT06562777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06562777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INvestigating Sex and Gender-Related Differences in Immunotherapy Treatment Effects (INSITE)
Lead sponsor
OHSU Knight Cancer Institute
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2023
Completion date
March 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphatic system neoplasm, malignant solid neoplasm